196 related articles for article (PubMed ID: 23223176)
1. Cell-based screening identifies paroxetine as an inhibitor of diabetic endothelial dysfunction.
Gerö D; Szoleczky P; Suzuki K; Módis K; Oláh G; Coletta C; Szabo C
Diabetes; 2013 Mar; 62(3):953-64. PubMed ID: 23223176
[TBL] [Abstract][Full Text] [Related]
2. Ion channel Piezo1 activation aggravates the endothelial dysfunction under a high glucose environment.
Zhang X; Leng S; Liu X; Hu X; Liu Y; Li X; Feng Q; Guo W; Li N; Sheng Z; Wang S; Peng J
Cardiovasc Diabetol; 2024 May; 23(1):150. PubMed ID: 38702777
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance associated protein-1 (MRP1) deficiency attenuates endothelial dysfunction in diabetes.
Neuser J; Fraccarollo D; Wick M; Bauersachs J; Widder JD
J Diabetes Complications; 2016; 30(4):623-7. PubMed ID: 26908299
[TBL] [Abstract][Full Text] [Related]
4. The novel mitochondria-targeted hydrogen sulfide (H
Gerő D; Torregrossa R; Perry A; Waters A; Le-Trionnaire S; Whatmore JL; Wood M; Whiteman M
Pharmacol Res; 2016 Nov; 113(Pt A):186-198. PubMed ID: 27565382
[TBL] [Abstract][Full Text] [Related]
5. Teaching an old drug new tricks: can paroxetine ease the burden of cardiovascular disease in diabetes?
Wheatcroft SB
Diabetes; 2013 Mar; 62(3):698-700. PubMed ID: 23431014
[No Abstract] [Full Text] [Related]
6. Glucocorticoids Suppress Mitochondrial Oxidant Production via Upregulation of Uncoupling Protein 2 in Hyperglycemic Endothelial Cells.
Gerö D; Szabo C
PLoS One; 2016; 11(4):e0154813. PubMed ID: 27128320
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function.
Suzuki K; Olah G; Modis K; Coletta C; Kulp G; Gerö D; Szoleczky P; Chang T; Zhou Z; Wu L; Wang R; Papapetropoulos A; Szabo C
Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13829-34. PubMed ID: 21808008
[TBL] [Abstract][Full Text] [Related]
8. Lycopene attenuates endothelial dysfunction in streptozotocin-induced diabetic rats by reducing oxidative stress.
Zhu J; Wang CG; Xu YG
Pharm Biol; 2011 Nov; 49(11):1144-9. PubMed ID: 21517710
[TBL] [Abstract][Full Text] [Related]
9. Natural therapeutic magnesium lithospermate B potently protects the endothelium from hyperglycaemia-induced dysfunction.
Kim SH; Kim SH; Choi M; Lee Y; Kim YO; Ahn DS; Kim YH; Kang ES; Lee EJ; Jung M; Cho JW; Williams DR; Lee HC
Cardiovasc Res; 2010 Sep; 87(4):713-22. PubMed ID: 20299332
[TBL] [Abstract][Full Text] [Related]
10. Dietary supplementation of the pyridoindole antioxidant stobadine reduces vascular impairment in streptozotocin-diabetic rats.
Sotnikova R; Stefek M; Okruhlicova L; Navarova J; Bauer V; Gajdosik A; Gajdosikova A
Methods Find Exp Clin Pharmacol; 2001 Apr; 23(3):121-9. PubMed ID: 11523310
[TBL] [Abstract][Full Text] [Related]
11. A role for diallyl trisulfide in mitochondrial antioxidative stress contributes to its protective effects against vascular endothelial impairment.
Liu LL; Yan L; Chen YH; Zeng GH; Zhou Y; Chen HP; Peng WJ; He M; Huang QR
Eur J Pharmacol; 2014 Feb; 725():23-31. PubMed ID: 24440170
[TBL] [Abstract][Full Text] [Related]
12. Ramipril improves oxidative stress-related vascular endothelial dysfunction in db/db mice.
Liang W; Tan CY; Ang L; Sallam N; Granville DJ; Wright JM; Laher I
J Physiol Sci; 2008 Dec; 58(6):405-11. PubMed ID: 18845058
[TBL] [Abstract][Full Text] [Related]
13. Luteolin reduces high glucose-mediated impairment of endothelium-dependent relaxation in rat aorta by reducing oxidative stress.
Qian LB; Wang HP; Chen Y; Chen FX; Ma YY; Bruce IC; Xia Q
Pharmacol Res; 2010 Apr; 61(4):281-7. PubMed ID: 19892019
[TBL] [Abstract][Full Text] [Related]
14. Minimizing Hyperglycemia-Induced Vascular Endothelial Dysfunction by Inhibiting Endothelial Sodium-Glucose Cotransporter 2 and Attenuating Oxidative Stress: Implications for Treating Individuals With Type 2 Diabetes.
Pulakazhi Venu VK; El-Daly M; Saifeddine M; Hirota SA; Ding H; Triggle CR; Hollenberg MD
Can J Diabetes; 2019 Oct; 43(7):510-514. PubMed ID: 30930073
[TBL] [Abstract][Full Text] [Related]
15. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
[TBL] [Abstract][Full Text] [Related]
16. Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats.
Serizawa K; Yogo K; Aizawa K; Tashiro Y; Ishizuka N
Cardiovasc Diabetol; 2011 Nov; 10():105. PubMed ID: 22107602
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV protects against hyperglycemia-induced vascular endothelial dysfunction by inhibiting oxidative stress and Calpain-1 activation.
Nie Q; Zhu L; Zhang L; Leng B; Wang H
Life Sci; 2019 Sep; 232():116662. PubMed ID: 31323271
[TBL] [Abstract][Full Text] [Related]
18. Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase.
Soriano FG; Pacher P; Mabley J; Liaudet L; Szabó C
Circ Res; 2001 Oct; 89(8):684-91. PubMed ID: 11597991
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide prevents diabetes-induced endothelial dysfunction.
Woodman OL; Malakul W; Cao AH; Xu Q; Ritchie RH
Life Sci; 2008 Apr; 82(15-16):847-54. PubMed ID: 18302965
[TBL] [Abstract][Full Text] [Related]
20. Taurine rescues vascular endothelial dysfunction in streptozocin-induced diabetic rats: correlated with downregulation of LOX-1 and ICAM-1 expression on aortas.
Wang LJ; Yu YH; Zhang LG; Wang Y; Niu N; Li Q; Guo LM
Eur J Pharmacol; 2008 Nov; 597(1-3):75-80. PubMed ID: 18796303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
